X4 PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.15 USD | +6.48% |
|
-1.29% | +37.15% |
Chart calendar X4 Pharmaceuticals, Inc.
c3ed00c2915fb04e00a45a5f6.2GZxpxW1buTGwJtzNv1ZN2pidFyVh5IZW9BkAs1F2Tg.uyBG00_4IKyfh8tBcZE2BlsnLQzX76RtMJs3Nb8Ni3fqByHKVMU8pYyFwg~3133426040bb6808c386a6bb4f6a2cda
Upcoming events on X4 Pharmaceuticals, Inc.
Past events on X4 Pharmaceuticals, Inc.
| 2024-04-29 08:30 | XOLREMDI™ FDA Approval Call |
| 2024-04-16 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-08 09:30 | Needham Healthcare Conference |
| 2024-03-21 08:30 | Q4 2023 Earnings Call |
| 2024-03-21 06:01 | Q4 2023 Earnings Release |
| 2023-11-28 13:00 | Piper Sandler Healthcare Conference |
| 2023-11-14 16:10 | Stifel Healthcare Conference |
| 2023-11-09 08:30 | Q3 2023 Earnings Call |
| 2023-11-09 06:01 | Q3 2023 Earnings Release |
| 2023-09-26 16:55 | Cantor Global Healthcare Conference |
| 2023-09-13 07:30 | Morgan Stanley Global Healthcare Conference |
| 2023-08-10 08:30 | Q2 2023 Earnings Call |
| 2023-08-10 06:05 | Q2 2023 Earnings Release |
| 2023-05-21 12:30 | Clinical Immunology Society Meeting |
| 2023-05-16 16:00 | 4WHIM Phase 3 Clinical Data Results Call |
| 2023-05-04 08:30 | Q1 2023 Earnings Call |
| 2023-05-04 06:05 | Q1 2023 Earnings Release |
| 2023-03-21 09:00 | Q4 2022 Earnings Call |
| 2023-03-21 06:05 | Q4 2022 Earnings Release |
| 2022-11-29 16:30 | 4WHIM Phase 3 Trial Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 3,00 2,25 33.33% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 21,6 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -51,7 -51,7 -0.01% | -59,9 -60,1 0.43% | -75,3 -76,0 0.8% | -87,6 -84,6 -3.46% | -108 -111 3.36% | -113 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,8 -55,2 4.41% | -62,0 -61,9 -0.08% | -88,7 -79,1 -12.16% | -93,8 -88,3 -6.31% | -101 -112 9.52% | -103 |
|
Net income Million USD | Released Forecast Spread | -53,4 -55,2 3.34% | -62,1 -62,0 -0.19% | -103 -79,5 -29.05% | -96,4 -89,3 -8.01% | -101 -112 9.5% | -103 |
|
EPS USD | Released Forecast Spread | -4,63 -4,47 -3.62% | -3,09 -3,08 -0.45% | -3,99 -3,08 -29.55% | -1,52 -1,43 -6.29% | -0,57 -0,63 10.14% | -0,48 |
| Announcement Date | 12/03/20 | 04/03/21 | 17/03/22 | 21/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,11 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 15,2 | 1,64 | 4,68 | 4,63 |
|
EBIT Million USD | Released Forecast Spread | -19,3 -19,9 2.99% | -21,3 -20,1 -5.97% | -20,6 -21,8 5.47% | -20,2 -20,9 3.36% | -25,6 -22,4 -14.22% | -29,3 -24,6 -18.98% | -25,8 -26,2 1.57% | -27,2 -26,3 -3.61% | -25,2 -28,9 12.94% | -29,5 | -18,4 | -33,2 | -31,5 | -32,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,2 -20,6 -46.71% | -21,9 -20,7 -6.01% | -21,2 -22,4 5.36% | -21,6 -21,4 -0.94% | -29,1 -23,2 -25.65% | -24,0 -25,3 5.13% | -55,7 -26,6 -109.07% | -2,28 -26,7 91.47% | -19,1 -29,7 35.78% | -30,2 | -5,87 | -34,0 | -32,4 | -34,4 |
|
Net income Million USD | Released Forecast Spread | -35,9 -19,9 -80.57% | -24,2 -20,7 -17.04% | -21,2 -22,4 5.34% | -21,9 -21,4 -2.22% | -29,1 -23,2 -25.71% | -24,0 -25,7 6.53% | -55,7 -26,6 -109.13% | -2,31 -26,7 91.37% | -19,1 -29,7 35.67% | -30,2 | -5,87 | -34,0 | -32,4 | -34,4 |
|
EPS USD | Released Forecast Spread | -1,24 -0,68 -81.59% | -0,72 -0,61 -18.31% | -0,60 -0,64 6.49% | -0,26 -0,30 13.33% | -0,29 -0,24 -20.21% | -0,16 -0,22 26.31% | -0,33 -0,17 -95.39% | -0,01 -0,15 93.28% | -0,10 -0,15 34.58% | -0,16 | -0,05 | -0,17 | -0,15 | -0,16 |
| Announcement Date | 17/03/22 | 12/05/22 | 04/08/22 | 03/11/22 | 21/03/23 | 04/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | - | - | - | - | - |
More events
Past sector events for X4 Pharmaceuticals, Inc.
| 2024-05-03 07:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-02 16:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 2024-05-02 11:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XFOR Stock
- Calendar X4 Pharmaceuticals, Inc.
